Our xTAG® and MultiCode®-RTx Technologies serve a wide range of clinical applications, including infectious disease testing, providing exceptional sensitivity and specificity, unmatched throughput flexibility, and increased assay speed.

Read More

Research & Applied Markets

Our xMAP® Technology and its flexible, open-architecture design is used in a wide variety of applications, from academic and clinical research to biodefense and clinical diagnostics.

Read More


Become a Partner

Our Business Development team invites you to contact them to explore your potential development and commercialization applications using our xMAP® Technology. Click here to start the conversation now.

Learn More


Luminex® Blog

The Faces of Luminex: Carrie Prehoda, Accounting

Keeping the financial statements for any company is a critical job, but especially so for a publicly traded firm like Luminex that has to report its finances to the U.S. Securities and Exchange Commission. We trust our data to Carrie Prehoda, Manager of Accounting and Stock Plan Administration, who joined the company in 2016.

Continue Reading >

Using Luminex to Help Treat Respiratory Patients



Dr. Gonzalez is a family practitioner who treats an eclectic mix of patients, young and old. He runs a smart practice and knows the value of syndromic testing as well as when a targeted approach makes better sense, especially when testing for a potential respiratory illness. Watch how he works to strategically treat two types of patients with respiratory infections.

Watch more videos >

Luminex on Twitter

RT @Luminex: Minimizing contamination in a molecular lab continues to be a hot topic. This blog is one of our most viewed since 2014. Check…
h J R
RT @Luminex: The #NxTAG Respiratory Pathogen Panel simultaneously detects 20 viral & bacterial pathogens known to cause respiratory infecti…
h J R
RT @Luminex: What lured #biotechnology student Shubhagata Das out of the lab and into the boardroom? Find out in this #FacesofLuminex. http…
h J R

Latest News

February 4
Luminex Corporation Reports Fourth Quarter and Full-Year 2018 Financial Results

January 2
Luminex Corporation Completes Acquisition of MilliporeSigma’s Flow Cytometry Portfolio

November 5
Luminex Corporation Reports Third Quarter 2018 Financial Results

October 18
Luminex Corporation to Acquire MilliporeSigma’s Flow Cytometry Portfolio

October 15
Luminex Corporation Third Quarter Earnings Release Scheduled for November 5, 2018


3rd Annual Middle Tennessee Antimicrobial Stewardship Symposium
February 1
Nashville, TN

Twenty Sixth Annual First Coast Infectious Disease/Clinical Microbiology Symposium
February 1-2
Palm Coast, FL

12th Annual FlowTex Conference
February 6-7
Houston, TX